Pablo
Irimia Sieira
Consultor Médico
![Foto de Pablo](/img/nophoto.png)
![Foto de Instituto de Investigación Sanitaria Aragón](/img/noimage_org.png)
Instituto de Investigación Sanitaria Aragón
Zaragoza, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Aragón (6)
2024
-
Nueva era terapéutica para el ataque de migraña con los recientemente aprobados anticuerpos monoclonales, ditanes y gepantes
Revista de neurologia, Vol. 78, Núm. 2, pp. 47-57
2023
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
2022
-
Cutaneous Allodynia in Migraine: A Narrative Review
Frontiers in Neurology, Vol. 12
2021
-
Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 2, pp. 285-297
-
Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas
Scientific Reports, Vol. 11, Núm. 1
2020
-
Estimating the savings associated with a migraine-free life: results from the Spanish Atlas
European Journal of Neurology, Vol. 27, Núm. 12, pp. 2616-2624